'Billy Connolly says he's no idea who Parkinson was and just wishes he'd kept his disease to himself. He should read this book.' Jeremy Paxman Parkinson's disease is one of the most common forms of dementia, with 10,000 new cases each year in the UK alone, and yet few know anything about the man the disease is named after. In 1817 - exactly 200 years ago - James Parkinson (1755-1824) defined the disease so precisely that we still diagnose it today by recognising the symptoms he identified. The story of this remarkable man's contributions to the Age of the Enlightenment is told through his three passions - medicine, politics and fossils. As a political radical Parkinson was interrogated over a plot to kill King George III and revealed as the author of anti-government pamphlets, a crime for which many were transported to Australia; while helping Edward Jenner set up smallpox vaccination stations across London, he wrote the first scientific study of fossils in English, which led to fossil-hunting becoming the nation's latest craze - just a glimpse of his many achievements. Cherry Lewis restores this neglected pioneer to his rightful place in history, while creating a vivid and pungent portrait of life as an 'apothecary surgeon' in Georgian London.

This Brief provides a concise review of chaperonopathies, i.e., diseases in which molecular chaperones play an etiologic-pathogenic role. Introductory chapters deal with the chaperoning system and chaperoning teams and networks, HSP-chaperone subpopulations, the locations and functions of chaperones, and chaperone genes in humans. Other chapters present the chaperonopathies in general, including their molecular features and mechanistic classification into by defect, excess, or mistake. Subsequent chapters discuss the chaperonopathies in more detail, focusing on their distinctive characteristics: primary or secondary; quantitative and/or qualitative; structural and hereditary or acquired; genetic polymorphisms; gene dysregulation; age-related; associated with cancer, chronic inflammatory conditions, and autoimmune diseases. The interconnections between the chaperoning and the immune systems in cancer development, chronic inflammation, autoimmunity, and ageing are outlined, which leads to a discussion on the future prospects of chaperonotherapy. The latter may consist of chaperone gene and protein replacement/supplementation in cases of deficiency and of gene or protein blocking when the chaperone actively promotes disease. The last chapter presents the extracellular chaperones and details on how the chaperone Hsp60 is secreted into the extracellular space and, thus, appears in the blood of cancer patients with potential to participate in carcinogenesis and chronic inflammation and autoimmunity. Chaperones as clinically useful biomarkers are mentioned when pertinent. Likewise, guidelines for clinical evaluation of chaperonopathies and for their histopathological and molecular identification are provided throughout. The book also provides extensive bibliography organized by chapter and topic with comments. "

Since the cloning of the cystic fibrosis transmembrane conductance re- lator (CFTR) nearly a decade ago, cystic fibrosis (CF) research has witnessed a dramatic expansion into new scientific areas. Basic researchers, clinicians, and patients increasingly rely on fundamental techniques of genetics, molecular biology, electrophysiology, biochemistry, cell biology, microbiology, and immunology to understand the molecular basis of this complex disease. Research into the pathophysiology of CF has established numerous paradigms of ion channel dysfunction that extend from inflammation and infection in the airways of patients to basic mechanisms of protein processing and regulation in intracellular components. With these rapid advances has come an increasing need for research scientists to understand and utilize a growing array of basic laboratory tools. This volume of Methods in Molecular Medicine, Cystic Fibrosis Methods and Protocols satisfies that need by providing detailed protocols for the laboratory techniques used throughout CF research. From electrophysiology and cell biology, to animal models and gene therapy, the comprehensive set of methods covered here provide step-by-step instructions needed for investigators to incorporate new approaches into their research programs. Contributions have been chosen to reflect the rich diversity of techniques and to provide a cohesive framework for understanding challenges that are currently at the forefront of CF research. It is hoped that this volume will serve as a valuable reference that will not only foster interdisciplinary investigations into current problems encountered in CF, but also facilitate the translation of new scientific discoveries into clinical solutions.

G Serratrice Les organisateurs de ce symposium en ont choisi le titre: " Syndrome de fatigue chronique ", titre dont chacun des termes doit etre defini avec precision, ce qui, paradoxalement, n'est pas aise. Syndrome: ensemble de symptomes ou de signes s'observant dans des etats pathologiques differents mais ne determinant pas a eux seuls la cause de la maladie. Fatigue: symptome plus ou moins exprime, moteur, intellectuel, sensoriel, sexuel selon les cas. Mais aussi signe traduit par l'incapacite a maintenir une force initiale pendant un effort continu. Ceci separe la fatigue de la faiblesse, qui est l'incapacite a produire une force. Stricto sensu, l'asthenie et la fai- blesse sont equivalentes. Mais l'usage, tout au moins en France, fait souvent confondre asthenie et fatigue. Chronique enfin. C'est sans doute sur cet adjectif que s'accumulent les plus grandes ambiguites. La simple lecture du programme d'aujour- d'hui indique la difficulte de se situer entre une definition stricte - chronique signi- fiant " permanent ", " qui dure " - et l'usage, surtout dans l'acception anglo-ameri- caine, qui reserve l'appellation de chronique a une forme particuliere de fatigue, parfois dite post-virale. En fait, il convient, pour une claire comprehension, de sepa- rer ce que l'on pourrait nommer les etats de fatigue chronique " determines " dans leur mecanisme et ceux qui restent " indetermines ". A l'evidence, les etats dont le mecanisme est determine sont tres diversifies.

Hughes Syndrome: The Antiphospholipid Syndrome, A Guide for Students provides an in-depth analysis into the main effects of Hughes Syndrome. In 1983, Dr Graham Hughes, and his team in London, described a syndrome and subsequently developed simple blood tests to diagnose the condition. This syndrome is characterised by thrombosis (both in limbs and internal organs), headaches, memory loss, strokes and, in pregnant women, placental clotting and recurrent miscarriage. The syndrome, now known worldwide as Hughes Syndrome, or the Antiphospholipid Syndrome, is common - being responsible for example, for up to 1 in 5 cases of young stroke and more importantly, it is treatable. Hughes Syndrome: The Antiphospholipid Syndrome, A Guide for Students details the effects of Hughes Syndrome on the major organs, making it a valuable reference tool for students in training.

Hepatologie konkret - komplett - kompakt Erfahrene Kliniker fuhren ubersichtlich, zusammenfassend und gewichtet durch das Gebiet der Leber- und Gallenwegserkrankungen. Komplexe Inhalte werden anschaulich, klar und gut verstandlich dargestellt. Differenzierte Diagnostik und Therapie: Was - Wann - Warum Neueste diagnostische und therapeutische Konzepte Rasche, prazise Information Konzentration auf krankheitsbezogene klinische Informationen Therapie individuell abgestimmt auf Ihre Patienten Standards Therapie fur multimorbide Patienten Loesungen fur typische und atypische Therapieprobleme Zur sofortigen sicheren Anwendung Entsprechend der neuesten Studien und Leitlinien aller wichtigen deutschen, europaischen und amerikanischen Fachgesellschaften

Whether in movies, cartoons, commercials, or even fast food marketing, psychology and mental illness remain pervasive in popular culture. In this collection of essays, domestic and international scholars from a range of fields explore representations of mental illness across various mediums of popular culture. Contributors address how forms of psychiatric disorder have been addressed in film, on stage, and in literature, examine how genres of popular culture are utilized to communicate our often confusing and conflicted relationship with the mentally ill, and investigate popular culture's reflection of mental illness around the world. Analyses of sources as disparate as the Batman films, Broadway musicals and Nigerian home movies reveal how definitions of mental illness, mental health, and of psychology itself intersect with discourses on race, gender, law, capitalism, and globalization.

Why do racial and ethnic controversies become attached, as they often do, to discussions of modern genetics? How do theories about genetic difference become entangled with political debates about cultural and group differences in America? Such issues are a conspicuous part of the histories of three hereditary diseases: Tay-Sachs, commonly identified with Jewish Americans; cystic fibrosis, often labeled a "Caucasian" disease; and sickle cell disease, widely associated with African Americans.

In this captivating account, historians Keith Wailoo and Stephen Pemberton reveal how these diseases -- fraught with ethnic and racial meanings for many Americans -- became objects of biological fascination and crucibles of social debate. Peering behind the headlines of breakthrough treatments and coming cures, they tell a complex story: about different kinds of suffering and faith, about unequal access to the promises and perils of modern medicine, and about how Americans consume innovation and how they come to believe in, or resist, the notion of imminent medical breakthroughs.

With Tay-Sachs, cystic fibrosis, and sickle cell disease as a powerful backdrop, the authors provide a glimpse into a diverse America where racial ideologies, cultural politics, and conflicting beliefs about the power of genetics shape disparate health care expectations and experiences.

Eight out of ten blind people live in the developing world, and the vast majority of this blindness is preventable. These facts constitute A Journey in Sight, a project by photographer Jarret Schecter who was astounded by the conditions he witnessed in Burkina Faso, one of the world's poorest countries. Here Schecter illuminates the link between poverty and blindness--40 million people suffer from preventable blindness that arises from Vitamin A deficiency, unsanitary conditions, minimal health care, and other issues. Presented are touching and heartfelt images of these persons in their habitats. But this isn't merely a journey into the world's less fortunate regions--a percentage of each sale of A Journey in Sight will be donated to Orbis, an organization that provides free or inexpensive eye treatment to people who needlessly suffer from preventable blindness.

Severe pain, debilitating fatigue, sleep disruption, severe gastrointestinal distress these hallmarks of chronic illness complicate treatment as surely as they disrupt patients lives, in no small part because of the overlap between biological pathology and resulting psychological distress. Cognitive Behavioral Therapy for Chronic Illness and Disability cuts across formal diagnostic categories to apply proven therapeutic techniques to potentially devastating conditions, from first assessment to end of treatment.

Four extended clinical case examples of patients with chronic fatigue, rheumatoid arthritis, inoperable cancer, and Crohn s disease are used throughout the book to demonstrate how cognitive-behavioral interventions can be used to effectively address ongoing medical stressors and their attendant depression, anxiety, and quality-of-life concerns. At the same time, they highlight specific patient and therapist challenges commonly associated with chronic conditions.

From implementing core CBT strategies to ensuring medication compliance, Renee Taylor offers professionals insights for synthesizing therapeutic knowledge with practical understanding of chronic disease. Her nuanced client portraits also show how individual patients can vary even within themselves.

This book offers clinicians invaluable help with

- Conceptualizing patient problems

- Developing the therapeutic relationship

- Pacing of therapy

- Cognitive restructuring

- Behavioral modification

- Problem solving

- Fostering coping and adapting skills

Taylor s coverage is both clean and hands-on, with helpful assessments and therapy worksheets for quick reference. Cognitive Behavioral Therapy for Chronic Illness and Disability gives practitioners of CBT new insights into this population and provides newer practitioners with vital tools and tactics. All therapists will benefit as their clients can gain new confidence and regain control of their lives."

The treatment outlined in this therapist guide is intended for people suffering from depression and living with chronic illnesses. As a result of their poor health, many individuals who are chronically ill become depressed and fail to maintain steady self-care routines. Using this guide, therapists can help clients with chronic illnesses to develop core skills and tecniques that will enable them to take better care of themselves. The program incorporates a unique Life-Steps module that teaches clients strategies for keeping up with their medical regimens, including tips for remembering to take medications, getting to medical appointments on time, and communicating effectively with medical providers. Based on the principles of CBT, this guide provides therapists with overviews of adherence behaviours for select illnesses including cancer, HIV, diabetes, and hypertension, among others. The chapters detail adherence skills, integrated with cognitive and behavioural strategies for managing depression such as managing pleasurable activities, adaptive thinking, problem-solving, and relaxation training. The guide concludes with suggestions on how clients can manage their illnesses and avoid relapse into behaviours that worsen their medical condition.

We must take applied epigenetics concepts from the ivory tower of the academics down to daily healthy practice! This third book in the trilogy of Your Body Is A Self-Healing Machine explains the basics of applied epigenetics and its practical use. It is in this book Your Body is a Self-Healing Machine: Understanding How Epigenetics Heals You where you will learn how you can reprogram epigenetics information to influence your gene expression. Your decisions, either big or small, on each factor, will positively or negatively update or downgrade your epigenome. What you feel, think, eat, breathe, drink, sleep, sun exposure, detox, fast and pray are all epigenetic information that tweaks your gene expression on or off. Dr. Siton's intention is to make applied epigenetics become a medical movement. This movement must spread like wildfire throughout the world. Applied epigenetics is a new medical paradigm that will reach far and wide, beyond cultural and geographical boundaries. It will become a compelling tool in the practice of medicine. It will be mainstreamed medical intervention as anti-biotics and vitamins. The author sincerely hopes that she has given enough information to inspire you to become passionate and practice applied epigenetics. Experience how simple it can be to apply your body's self-healing tools in your daily life after reading the trilogy of Your Body Is A Self-Healing Machine!

The most fascinating and unique feature of prion diseases is that they are caused almost exclusively by a proteinaceous and infectious particle termed prions by the Nobel Prize laureate S B Prusiner, who discovered this class of pathogens. In the latter part of the 1990s, mad-cow disease, a disease caused by prions acquired through foodborne transmission, raised unprecedented public concern due to the concrete possibility that prions in animals could be transmitted to humans through the food chain. For roughly two decades, prions were under intense scrutiny and many studies were undertaken worldwide. These investigations have led our community to a better risk assessment and management of prion diseases in humans and in animals, substantially limiting the possibility of new prion epidemics. Nowadays, prions have been brought once again to the foreground after the discovery that a variety of neurodegenerative diseases, in particular Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, share fundamental features with prions, including protein misfolding and aggregation in the brain, cell-to-cell transmission and in vivo infectivity. Therefore, studying prions might help to understand the pathological mechanism of these disorders. The Prion Phenomena In Neurodegenerative Diseases: New Frontiers in Neuroscience is a book that benefits from the contribution of leading scientists in different fields of neuroscience, including Gianluigi Zanusso, Holger Wille, Fabrizio Tagliavini, Andrew F Hill, Jerson L Silva, Vladimir N Uversky, Henrike Heise, David W Colby, Neil R Cashman and the Nobel Prize laureate Eric R Kandel. This chapter collection discusses the development of prions and their various diseases, and provides a detailed overview about the state of the art of the novel prion phenomena observed in other fatally damaging protein misfolding disorders. This book represents an up-to-date review of different protein-misfolding diseases, serving as an invaluable tool for both specialized researchers working in the field of neurodegeneration and for a broad spectrum of academic readers that wish to learn more about the prion phenomena.

Osteoporosis currently affects 25 million people in the United States, and as the baby boomers enter their fifties, this bone-weakening disease is poised to strike millions more. Because of this disease, many older people will suffer from a bone fracture at some point , and far too many of these fractures will result in permanent disability. The good news is that this devastating "silent epidemic" is entirely preventable, and in The Osteoporosis Book, readers of all ages will find everything they need to know to slow, stop, and even reverse the bone loss that causes this crippling disease. Written by Dr. Nancy E. Lane, a leading investigator and clinician in the field of osteoporosis, it is an indispensable guide to the exciting medical breakthroughs that have taken place in the past few years--in bone density measurement, in estrogen therapy, and in our knowledge of the bone cycle--that now allow doctors to predict who is at risk and to monitor these individuals in their fifties, before a fracture occurs. Readers learn to evaluate--and whenever possible, eliminate--the risk factors in their own lives. "What vitamins should I take? Is hormone replacement therapy right for me? And what about exercise?" The answers are here. And for those already affected by osteoporosis, Dr. Lane provides the most effective and up-to-date medical and practical advice available anywhere for coping with its aches and pains and safeguarding against further deterioration. Impeccably researched and reassuringly accessible, The Osteoporosis Book empowers readers to make informed healthcare choices that will enhance the quality of their lives for decades to come. It has been endorsed by the National Osteoporosis Foundation.

Wendy Lawson has an autism spectrum disorder. Considered to be intellectually disabled and "almost incapable of doing as she is told" at school, she was later misdiagnosed as schizophrenic - a label that stuck with her for more than 25 years.;Her sense of self was then non-existent, but Wendy is now a mother of four with two university degrees; she is a social worker and adult educator, and operates her own business. She is also a poet and writer, sharing her understanding of autism with others to help "build a bridge ...from my world to theirs". This book is part of that bridge.

There have been many exciting advances in our understanding of mammalian sex determination and differentiation in the last decade. Using these advances to elucidate clinical conditions of abnormal sexual development, the authors bring together great expertise in molecular endocrinology, molecular genetics, and dysmorphology. The text begins with a discussion of normal gonadal and sexual development that presents enough embryology, biochemistry, and endocrinology to make the remaining chapters easy to assimilate. Then the authors discuss overarching clinical issues that are common to genetic abnormalities of gonadal and sexual development, providing a detailed account of genetic causes of gonadal maldevelopment, followed by a compendium of the singular, syndromal, endocrinologic, and systemic-metabolic genetic causes of sexual maldevelopment. The final section describes genetic forms of gamete failure.
Seldom dogmatic, this unconventional textbook frequently presents alternatives, highlights speculation, raises questions, and attempts to provide answers. Yet it will be a uniquely valuable reference on an area of genetic medicine where much has happened in recent years. This book will be welcomed by medical geneticists, genetic counselors, endocrinologists, gynecologists, urologists, and students who need fully-referenced information about the genetic aspects of humans sexual maldevelopment in order to better manage their patients and their patients families.

This volume is based on presentations by world-renowned investigators who gathered at the 76th Cold Spring Harbor Symposium on Quantitative Biology. It reviews the latest advances in our understanding of metabolism and disease, including research on fat, exercise and rhythms; insulin resistance and sensitivity; lifespan, aging and cancer; regulation and dysregulation of metabolism; signaling and gene regulation; environment and sensing; metabolic reprogramming; clocks and intermediary metabolism; metabolism and cancer; and autophagy, timing and small RNAs.